JNJ

190.31

-0.15%↓

ABT

127.15

+0.3%↑

MDT

94.09

+0.34%↑

VEEV

295.48

+0.77%↑

A

146.74

-0.99%↓

JNJ

190.31

-0.15%↓

ABT

127.15

+0.3%↑

MDT

94.09

+0.34%↑

VEEV

295.48

+0.77%↑

A

146.74

-0.99%↓

JNJ

190.31

-0.15%↓

ABT

127.15

+0.3%↑

MDT

94.09

+0.34%↑

VEEV

295.48

+0.77%↑

A

146.74

-0.99%↓

JNJ

190.31

-0.15%↓

ABT

127.15

+0.3%↑

MDT

94.09

+0.34%↑

VEEV

295.48

+0.77%↑

A

146.74

-0.99%↓

JNJ

190.31

-0.15%↓

ABT

127.15

+0.3%↑

MDT

94.09

+0.34%↑

VEEV

295.48

+0.77%↑

A

146.74

-0.99%↓

Search

Owens & Minor Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

5.5 0.18

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

5.41

Max

5.54

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-59M

-84M

Pardavimai

-2B

682M

Pelno marža

-12.292

Darbuotojai

20,000

EBITDA

-100M

-40M

Rekomendacijos

By TipRanks

Rekomendacijos

Neutralu

12 mėnesių prognozė

+14.6% upside

Dividendai

By Dow Jones

Kitas uždarbis

2025-10-30

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

27M

382M

Ankstesnė atidarymo kaina

5.32

Ankstesnė uždarymo kaina

5.5

Naujienos nuotaikos

By Acuity

34%

66%

92 / 373 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Strong Bearish Evidence

Owens & Minor Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-10-27 23:32; UTC

Įsigijimai, susijungimai, perėmimai

CSL Delays Flu-Vaccine Spinoff, Cuts Guidance As U.S. Vaccination Rates Decline

2025-10-27 23:00; UTC

Įsigijimai, susijungimai, perėmimai

Australia's AUB Opens Books to EQT After Receiving $3.44 Billion Takeover Offer

2025-10-27 21:42; UTC

Uždarbis

Waste Management 3Q Revenue Climbs, Sees Fiscal Year Revenue at Low End of Prior View

2025-10-27 23:43; UTC

Rinkos pokalbiai

Nikkei May Rise on Easing U.S.-China Trade Tensions -- Market Talk

2025-10-27 23:42; UTC

Rinkos pokalbiai

Gold Rises on Likely Technical Recovery -- Market Talk

2025-10-27 23:37; UTC

Rinkos pokalbiai

Investors May Cheer CSL's Decision to Delay Seqirus Spinoff -- Market Talk

2025-10-27 23:00; UTC

Uždarbis

The Good Vibes Are Back on Wall Street -- WSJ

2025-10-27 22:45; UTC

Įsigijimai, susijungimai, perėmimai

Australia's AUB Opens Books to EQT After Receiving $3.44B Takeover Offer

2025-10-27 22:06; UTC

Rinkos pokalbiai
Uždarbis

Nucor Expects Weaker Steel Market in 4Q -- Market Talk

2025-10-27 22:05; UTC

Uždarbis

China Southern Airlines: Continued Improvements in Business Environment Supported Results >1055.HK

2025-10-27 22:04; UTC

Uždarbis

Cadence Reports Solid Earnings. The Stock Is Falling. -- Barrons.com

2025-10-27 22:04; UTC

Uždarbis

China Southern Airlines 3Q Net CNY3.84B, Up 20.3% on Year >1055.HK

2025-10-27 22:03; UTC

Uždarbis

China Southern Airlines 3Q Rev CNY51.37B, Up 3.0% on Year >1055.HK

2025-10-27 21:27; UTC

Uždarbis

Waste Management 3Q Rev Climbs, Sees FY Rev at Low End of Prior View

2025-10-27 21:19; UTC

Uždarbis

Cadence Reports Solid Earnings. The Stock Is Falling. -- Barrons.com

2025-10-27 20:50; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Health Care Roundup: Market Talk

2025-10-27 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-10-27 20:37; UTC

Uždarbis

Waste Management: Decrease From Prior Rev Expectations Is Primarily Related to Further Decline in Recycled Commodity Pricing, Modestly Lower Rev Expectations From Healthcare Solutions >WM

2025-10-27 20:37; UTC

Uždarbis

Waste Management: 2025 Free Cash Flow Guidance Remains Between $2.8B and $2.9B >WM

2025-10-27 20:37; UTC

Uždarbis

Waste Management: 2025 Total Co Rev Is Now Expected Approximately $25.275B >WM

2025-10-27 20:37; UTC

Uždarbis

Waste Management: Affirming 2025 Adjusted Operating EBITDA Guidance Between $7.475B and $7.625B >WM

2025-10-27 20:31; UTC

Uždarbis

Nucor Sees 4Q Earnings Lower Than 3Q

2025-10-27 20:30; UTC

Uždarbis

Nucor 3Q Steel Mills Total Shipments 6.43M Tons >NUE

2025-10-27 20:30; UTC

Uždarbis

Nucor 3Q EPS $2.63 >NUE

2025-10-27 20:30; UTC

Uždarbis

Nucor 3Q Net $607M >NUE

2025-10-27 20:30; UTC

Uždarbis

Nucor 3Q Sales $8.52B >NUE

2025-10-27 20:30; UTC

Uždarbis

Nucor 3Q Total Tons Shipped to Outside Customers Down 1% >NUE

2025-10-27 20:30; UTC

Uždarbis

Waste Management 3Q Adj EPS $1.98 >WM

2025-10-27 20:30; UTC

Uždarbis

Waste Management 3Q Rev $6.44B >WM

2025-10-27 20:30; UTC

Uždarbis

Waste Management 3Q Net $603M >WM

Akcijų palyginimas

Kainos pokytis

Owens & Minor Inc Prognozė

Kainos tikslas

By TipRanks

14.6% į viršų

12 mėnesių prognozė

Vidutinis 6.28 USD  14.6%

Aukščiausias 7 USD

Žemiausias 4.7 USD

Remiantis 6 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Owens & Minor Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

6 ratings

3

Pirkti

1

Laikyti

2

Parduoti

Techninis įvertinimas

By Trading Central

6.98 / 7.075Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Strong Bearish Evidence

Vidutinės trukmės periodas

Weak Bullish Evidence

Ilgalaikis periodas

Weak Bearish Evidence

Rinkos nuotaikos

By Acuity

92 / 373 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Owens & Minor Inc

Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, including supplier management, analytics, inventory management, and clinical supply management; and various programs to provide outsourced logistics and marketing solutions to its suppliers. The Patient Direct segment provides products and services for in-home care and delivery across diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment. This segment supplies a range of other home medical equipment, patient care products, including ostomy, wound care, urology, incontinence and other products and services. It serves multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. Owens & Minor, Inc. was founded in 1882 and is headquartered in Mechanicsville, Virginia.
help-icon Live chat